increas vertex fve strong promis
outlook cystic fibrosi beyond
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jan
estim
price data jan
rate updat jan
currenc amount express
methodolog valu compani
expect mid- high single-digit increas
fair valu estim narrow-moat vertex follow
biotech strong fourth-quart result manag
guidanc compani lead posit cystic
fibrosi therapi basi narrow econom moat
rate cement ahead-of-schedul
approv trikafta octob trikafta launch
surpass expect fourth quarter partial
help launch-rel inventori build roughli
million contribut million sale vertex
seen strong interest trikafta patient group
includ patient alreadi exist vertex therapi
full-year adjust oper incom nearli billion
last year total revenu
billion last year cf drug trikafta
symdeko drive top-lin growth fourth quarter
surpris see rapid rate convers
older vertex cf therapi kalydeco orkambi symdeko
trikafta plan adjust model account
faster-than-expect convers trikafta lift
sale estim substanti trikafta price
point rel vertex therapi
switch trikafta illustr drug attract profil
demonstr high bar futur competitor
includ eventu gener expect vertex
abl defend domin posit cf brand
gener competit thank long patent live
portfolio expertis indic continu
invest search next-gener therapi
look catalyst year look forward
see data vertex early-stag asset mark
compani key opportun pivot new diseas
area outsid cf anticip earli data
small molecul alpha-on antitrypsin defici
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
discov develop small-molecul drug
treatment seriou diseas key drug kalydeco orkambi
symdeko trikafta cystic fibrosi vertex therapi remain
standard care global vertex pipelin also includ therapi
cancer pain inflammatori diseas influenza rare diseas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
well addit data vertex crispr
therapeut gene therapi sickl cell diseas
beta thalassemia demonstr posit result
two patient late approv rare indic
high unmet need would solidifi vertex
competit posit narrow moat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
